Cite
APA Citation
Ghia, P., Pluta, A., Wach, M., Lysak, D., Simkovic, M., Kriachok, I., Illes, A., de la Serna, J., Dolan, S., Campbell, P., Musuraca, G., Jacob, A., Avery, E., Lee, J. H., Usenko, G., Wang, M. H., Yu, T., & Jurczak, W. (n.d.). p668: ACALABRUTINIB VS RITUXIMAB PLUS IDELALISIB OR BENDAMUSTINE IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: ASCEND RESULTS AT ~4 YEARS OF FOLLOW-UP. HemaSphere, 6, 566–567. http://access.bl.uk/ark:/81055/vdc_100159757189.0x00000f